Menveo is a vaccine used to protect against meningococcal disease, a serious bacterial infection that can cause meningitis and sepsis. It is a quadrivalent vaccine, meaning it protects against four different types of meningococcal bacteria. Menveo is approved for use in children and adults, and is recommended for routine immunization of adolescents and young adults. It is also recommended for people at increased risk of meningococcal disease, such as those with certain medical conditions, travelers to certain countries, and military personnel. Menveo is available in both single-dose and multi-dose vials, and is administered intramuscularly. It is manufactured by GlaxoSmithKline, and is distributed in the United States by Merck & Co. Other companies that produce meningococcal vaccines include Pfizer, Sanofi Pasteur, and Novartis. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
